Gilead Sciences, Inc. has announced that Trodelvy (sacituzumab govitecan-hziy) has received Breakthrough Therapy Designation ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK-positive locally advanced or metastatic ...

The treatment approach for germ cell tumors depends on the tumor type, whether ovarian or testicular. Surgery, followed by ...

Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Gilead announces that the FDA grants a second Breakthrough Therapy designation to Trodelvy for the extensive-stage small cell ...

LIAM Handley didn’t seem like a typical lung cancer patient. The 36-year-old from Glossop, in Derbyshire, was young, fit and a non-smoker – but he did have anxiety. So when the dad-of-four ...

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trialMonotherapy activity with ...

Woman from Central Texas thought she had allergies. Then she learned she had lung cancer, although she never smoked.